Ypsomed to Supply Novo Nordisk With Autoinjectors
By Cecilia Butini
Swiss medical-devices manufacturer Ypsomed said Wednesday that it will supply Novo Nordisk with a large amount of 1-milliliter autoinjectors as part of a long-term supply agreement.
The company said it will deliver auto-injectors to be used for various drugs, and that it will expand its manufacturing capacities over the coming years as a result.
Third-party manufacturers will also get the right to manufacture as part of a royalty scheme, said Ypsomed.
The supply agreement with the Danish pharma giant, however, won't have any material impact on the outlook for the current financial year, the company said.
Write to Cecilia Butini at cecilia.butini@wsj.com
Corrections & Amplifications
This was corrected at 1321 GMT because the original version incorrectly said it would supply one million auto-injectors.
(END) Dow Jones Newswires
September 20, 2023 05:59 ET (09:59 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk
United States